Compound Evidence File
#EC-2026-0490
Tirzepatide 30mg Pen Kit
Filed under Peptides. The bureau holds 115 laboratory returns for this compound from 44 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.
Cross-Index
Subjects Shipping This Compound
44 SUBJECTS| Subject | Grade | Samples | Mean | Min | Max | First seen | Last seen |
|---|---|---|---|---|---|---|---|
| Sangon BioCASE #VI-2026-0671 | A | 4 | 10.0 | 9.9 | 10.0 | 9 Jan 2026 | 4 Jun 2026 |
| Hybio PharmaceuticalCASE #VI-2026-0065 | A | 4 | 10.0 | 9.9 | 10.0 | 9 Jan 2026 | 6 May 2026 |
| PolyPeptide GroupCASE #VI-2026-0143 | A | 4 | 10.0 | 9.9 | 10.0 | 4 May 2026 | 14 Jul 2026 |
| AmbioPharmCASE #VI-2026-0177 | A | 4 | 10.0 | 9.9 | 10.0 | 15 Feb 2026 | 15 Jul 2026 |
| Chinese Peptide CompanyCASE #VI-2026-0184 | A | 3 | 10.0 | 9.9 | 10.0 | 19 Jan 2026 | 4 Jul 2026 |
| WuXi TIDESCASE #VI-2026-0335 | A | 3 | 10.0 | 10.0 | 10.0 | 6 May 2026 | 13 Jun 2026 |
| GenScript PeptidesCASE #VI-2026-0860 | A | 3 | 10.0 | 10.0 | 10.0 | 24 Mar 2026 | 25 Jun 2026 |
| JEEP PeptidesCASE #VI-2026-0457 | A | 2 | 10.0 | 10.0 | 10.0 | 25 Apr 2026 | 27 May 2026 |
| Tianjin Finder Chemical TFCCASE #VI-2026-0693 | A | 5 | 9.9 | 9.9 | 10.0 | 14 Nov 2025 | 16 Apr 2026 |
| HomopeptideCASE #VI-2026-0760 | A | 4 | 9.9 | 9.9 | 10.0 | 24 May 2026 | 24 May 2026 |
| QYAOBIOCASE #VI-2026-0861 | A | 4 | 9.9 | 9.9 | 10.0 | 12 Nov 2025 | 18 Jun 2026 |
| Shanghai ERP BiotechnologyCASE #VI-2026-0936 | A | 3 | 9.9 | 9.9 | 10.0 | 2 Feb 2026 | 6 May 2026 |
| Kerui PeptidesCASE #VI-2026-0626 | A | 3 | 9.9 | 9.9 | 10.0 | 24 Feb 2026 | 9 Jun 2026 |
| Mokemei BiotechnologyCASE #VI-2026-0540 | A | 3 | 9.9 | 9.9 | 10.0 | 1 Feb 2026 | 1 Jul 2026 |
| Thermo Fisher ScientificCASE #VI-2026-0142 | A | 3 | 9.9 | 9.9 | 10.0 | 20 Mar 2026 | 11 Jun 2026 |
| BachemCASE #VI-2026-0314 | A | 2 | 9.9 | 9.9 | 10.0 | 3 Mar 2026 | 3 May 2026 |
| Hubei JianxiangCASE #VI-2026-0048 | A | 2 | 9.9 | 9.9 | 10.0 | 13 Feb 2026 | 6 May 2026 |
| Flourishglobal PeptideCASE #VI-2026-0630 | A | 2 | 9.9 | 9.9 | 10.0 | 3 May 2026 | 12 Jul 2026 |
| Shanghai Wibson BiotechnologyCASE #VI-2026-0379 | A | 2 | 9.9 | 9.9 | 10.0 | 11 May 2026 | 14 Jul 2026 |
| Shanghai Sigma AudleyCASE #VI-2026-0505 | A | 2 | 9.9 | 9.9 | 10.0 | 3 May 2026 | 3 May 2026 |
| Sigma-AldrichCASE #VI-2026-0829 | A | 2 | 9.9 | 9.9 | 10.0 | 24 Jan 2026 | 19 Aug 2026 |
| SinoPepCASE #VI-2026-0387 | A | 2 | 9.9 | 9.9 | 9.9 | 25 Dec 2025 | 11 May 2026 |
| AsymchemCASE #VI-2026-0091 | A | 2 | 9.9 | 9.9 | 10.0 | 19 Jun 2026 | 23 Jul 2026 |
| HkRoidsCASE #VI-2026-0784 | X | 1 | 9.5 | 9.5 | 9.5 | 28 Mar 2025 | 28 Mar 2025 |
| Nantong Guangyuan Chemical GYCCASE #VI-2026-0284 | A | 6 | 8.8 | 7.1 | 9.6 | 24 May 2026 | 24 May 2026 |
| Qingdao Sigma Chemical QSCCASE #VI-2026-0538 | A | 4 | 8.8 | 8.1 | 9.2 | 24 May 2026 | 24 May 2026 |
| Peptide TechnologiesCASE #VI-2026-0694 | X | 1 | 8.8 | 8.8 | 8.8 | 25 Apr 2025 | 25 Apr 2025 |
| Glbiochem (Shanghai)CASE #VI-2026-0704 | A | 4 | 8.7 | 7.9 | 9.6 | 21 May 2026 | 21 May 2026 |
| Henan Sahe PeptideCASE #VI-2026-0894 | X | 1 | 8.7 | 8.7 | 8.7 | 17 Dec 2024 | 17 Dec 2024 |
| Shenzhen Jiechuang TradingCASE #VI-2026-0292 | X | 1 | 8.7 | 8.7 | 8.7 | 16 Mar 2025 | 16 Mar 2025 |
| Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594 | A | 7 | 8.1 | 6.3 | 10.0 | 21 May 2026 | 21 May 2026 |
| NexaphCASE #VI-2026-0944 | X | 4 | 7.8 | 6.0 | 9.0 | 17 Dec 2024 | 24 May 2026 |
| Pura PeptidesCASE #VI-2026-0307 | X | 1 | 7.7 | 7.7 | 7.7 | 8 Jul 2025 | 8 Jul 2025 |
| Xingruida XDRCASE #VI-2026-0898 | X | 1 | 7.6 | 7.6 | 7.6 | 2 Apr 2025 | 2 Apr 2025 |
| Shanghai Sigma Audley SSACASE #VI-2026-0486 | A | 3 | 7.2 | 6.6 | 8.2 | 24 May 2026 | 24 May 2026 |
| Nuscience PeptidesCASE #VI-2026-0554 | X | 4 | 6.8 | 5.9 | 8.6 | 3 Jul 2025 | 19 Jan 2026 |
| Qingdao Hongshengda TradingCASE #VI-2026-0334 | X | 1 | 6.7 | 6.7 | 6.7 | 13 Jun 2025 | 13 Jun 2025 |
| Anlv BiotechnologyCASE #VI-2026-0110 | X | 1 | 6.2 | 6.2 | 6.2 | 21 May 2025 | 21 May 2025 |
| Wolverine PeptidesCASE #VI-2026-0262 | X | 1 | 5.8 | 5.8 | 5.8 | 7 May 2025 | 7 May 2025 |
| Platinum CryoCASE #VI-2026-0406 | X | 1 | 5.8 | 5.8 | 5.8 | 27 Feb 2025 | 27 Feb 2025 |
| Xingtai Lesda TechnologyCASE #VI-2026-0381 | X | 1 | 5.6 | 5.6 | 5.6 | 17 Dec 2024 | 17 Dec 2024 |
| LN PeptidesCASE #VI-2026-0781 | X | 2 | 5.3 | 3.1 | 7.5 | 16 Mar 2025 | 23 May 2026 |
| PeptiLab ResearchCASE #VI-2026-0267 | X | 1 | 3.2 | 3.2 | 3.2 | 8 Jul 2025 | 8 Jul 2025 |
| Lejian Biotech PeptideCASE #VI-2026-0746 | X | 1 | 0.0 | 0.0 | 0.0 | 8 Jul 2025 | 8 Jul 2025 |
Open any subject to view the batch-level evidence for Tirzepatide 30mg Pen Kit alone.